How do I buy Taysha Gene Therapies, Inc. Common Stock (TSHA) stock?

Buying Taysha Gene Therapies, Inc. Common Stock (TSHA) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "TSHA", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy TSHA by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if TSHA is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Taysha Gene Therapies, Inc. Common Stock (TSHA) Stock

Q: What is the minimum investment for TSHA on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Taysha Gene Therapies, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · TSHA

Trade TSHA

Key stats

Market cap: $1.39B
Price / Earnings ratio: -9.3x
EPS (TTM): -$0.42
Volume: Loading
52-week high: $7.30
52-week low: $3.46

Source: third-party data provider, as of November 13, 2026

Compare with TSHA

Technical indicators

RSI 14: 49.74
MACD 12/26/9: -0.06
EMA 9 of MACD: -0.13
MACD histogram: 0.07
SMA 50: $4.55; Price below SMA 50
EMA 50: $4.56; Price below EMA 50
SMA 200: $5.30; Price below SMA 200
EMA 200: $5.05; Price below EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 1 analyst rating

Strong Sell0

Sell0

Hold0

Buy1

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2021

2022

2023

2024

2025

19M12M6M0

Debt & Balance Sheet

Total assets

Total liabilities

2021

2022

2023

2024

2025

412M272M136M0

Revenue to Profit

2025

$9.8M

Revenue

$0.0

Cost of revenue

$9.8M

Gross profit

$0.0

Operating expenses

$-109.0M

Net income

Earnings

EPS forecast

Actual EPS

$-0.10

Q1FY26

$-0.10

Q2FY26

$-0.10

Q3FY26

The market is expecting earnings per share of -$0.10 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About Taysha Gene Therapies, Inc. Common Stock

No description available.

SectorHealthcare

IndustryBiotechnology

Employees99

CEOMr. Sean P. Nolan

IPO DateSep 24, 2020

HeadquartersDallas, TX

Key Executives

Name	Title	Year Born
Mr. Sean P. Nolan	CEO & Chairman	1968
Mr. Kamran Alam CPA, M.B.A.	CFO & Corporate Secretary	1978
Dr. Sukumar Nagendran M.D.	President, Head of Research & Development and Director	1967
Hayleigh Collins	Director of Corporate Communications & Investor Relations	—
Mr. Michael B. Johannesen	Chief Legal Officer & Corporate Secretary	1966
Mr. Frederick Porter Ph.D.	Chief of Staff & Technical Operations Officer	—
Ms. Emily McGinnis M.P.H.	Chief Patient & External Affairs Officer	—
Mr. Sean McAuliffe	Chief Business Officer	—
Dr. Steven Gray Ph.D.	Chief Scientific Advisor of UT Southwestern Gene Therapy Program	—
Berge Minassian M.D.	Chief Medical Advisor of UT Southwestern Gene Therapy Program	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-10.5	-5.6
2022	-33.0	-22.3	-0.9	-42.3	-35.3	+50.6	+18.0	-22.9	-40.2	-19.2	+21.4	+3.7
2023	-25.5	-16.5	-23.1	+1.3	-1.4	-12.0	+6.3	+370.6	-12.9	-19.0	-26.4	-3.8
2024	-11.1	+102.6	-11.1	-14.4	+41.7	-38.1	-2.2	+3.7	-2.4	-16.3	+111.8	-43.8
2025	-18.9	+4.6	-14.2	+52.8	+12.4	-17.2	+16.7	+11.0	+15.1	+56.0	+6.3	+24.2
2026	-14.1	-2.8	-1.3	+48.3	-7.3	+14.1	-11.9	-1.6	-14.6	-12.9	+7.0

Stocks in the same sector

Vertex Pharmaceuticals

ABEO

Abeona Therapeutics Inc.

FAQ

Buying Taysha Gene Therapies, Inc. Common Stock (TSHA) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and verify your identity.
Make a deposit.
Search for the code "TSHA", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy TSHA by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in Taysha Gene Therapies, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Taysha Gene Therapies, Inc. Common Stock (TSHA) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track TSHA's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.

The market is closed on US public holidays. The Gotrade app shows whether the market is open.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Taysha Gene Therapies, Inc. Common Stock (TSHA) Stock

Key stats

Compare with TSHA

Recent news

These 3 Risky Stocks Could Be Sitting on 100% Upside

These 3 Risky Stocks Could Be Sitting on 100% Upside

Taysha Gene Therapies Q2 Earnings Call Highlights

Taysha Gene Therapies Q2 Earnings Call Highlights

Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul

Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul

Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

These 3 Risky Stocks Could Be Sitting on 100% Upside

These 3 Risky Stocks Could Be Sitting on 100% Upside

Taysha Gene Therapies Q2 Earnings Call Highlights

Taysha Gene Therapies Q2 Earnings Call Highlights

Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul

Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul

Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

3 Growth Stocks That Could Go Parabolic in 2024

3 Growth Stocks That Could Go Parabolic in 2024

2 Healthcare Stocks That More Than Tripled Recently. Can They Keep Climbing?

2 Healthcare Stocks That More Than Tripled Recently. Can They Keep Climbing?

3 Small-Cap Stocks to Sell in September Before They Crash & Burn

3 Small-Cap Stocks to Sell in September Before They Crash & Burn

About Taysha Gene Therapies, Inc. Common Stock

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade